This weight-loss drug hasn't been approved by the FDA. Doctors are prescribing it anyway. – CBS News
This weight-loss drug hasn’t been approved by the FDA. Doctors are prescribing it anyway. CBS NewsHow an experimental weight-loss…
Revolution Medicines starts early access for pancreatic cancer drug
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Multiple injuries reported after chemical explosion at Longview facility
LONGVIEW, Wash. (KPTV) – Multiple injuries have been reported after a chemical explosion at a facility in Longview…
Marty Makary didn’t understand the FDA’s administrative power
On Tuesday, Food and Drug Administration Commissioner Marty Makary resigned from his position, leaving a vacancy at the…
FDA leadership void grows: Tracy Beth Høeg out as CDER chief
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
Controversial FDA official leaving drug center post in latest departure at agency
The leader of the Food and Drug Administration division responsible for regulating prescription and over-the-counter drugs is leaving…
Kyle Diamantas, New FDA Commissioner, Is Don Jr.’s Hunting Buddy
If you’ve ever swallowed an aspirin, put milk in your coffee, fed your pet, or filled a prescription,…
Trump set to fire FDA Commissioner Marty Makary after stormy tenure
President Trump has reportedly signed off on a plan to dismiss Food and Drug Administration Commissioner Marty Makary.…
Utz recalls famous potato chip snacks due to salmonella risk
Nine varieties of salty snacks from a leading national manufacturer were recalled this week amid concerns over a…
Intellia Therapeutics moves HAE treatment closer to approval
Intellia Therapeutics said Monday that a single dose of its gene editing treatment dramatically reduced swelling attacks in…
FDA peptide advisers expected to support RFK Jr.’s legalization push
WASHINGTON — The Food and Drug Administration will convene an outside panel of advisers to discuss whether to…
Replimune skin cancer drug that became FDA flashpoint is rejected again
The Food and Drug Administration on Friday rejected — again — an experimental treatment for advanced skin cancer…